Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management by Ryan Yip, Jennifer Swainson, Jennifer Swainson, Atul Khullar, Atul Khullar, Atul Khullar, Roger S. McIntyre, Roger S. McIntyre, Roger S. McIntyre, Roger S. McIntyre, Kevin Skoblenick, Kevin Skoblenick, Kevin Skoblenick

Get full text

Peripheral pulmonary embolism: A missed entity by J Sankar, Manish Unniyal, R Ramprasad, Atul Khullar

Get full text

The drug liking and craving questionnaire (DLCQ) to evaluate addiction risk for ketamine and esketamine by Jay Wang, Atul Khullar, Roger S. McIntyre, Jennifer Swainson

Get full text

Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada by Carson Chrenek, Bryan Duong, Atul Khullar, Chris McRee, Rejish Thomas, Jennifer Swainson

Get full text

A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression: A preliminary evaluation of real world addictive potent... by Brittany Chubbs, Jay Wang, Shaina Archer, Carson Chrenek, Atul Khullar, Michael Wolowyk, Jennifer Swainson

Get full text

Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression by Raymond Yan, Tyler Marshall, Atul Khullar, Travis Nagle, Jake Knowles, Mai Malkin, Brittany Chubbs, Jennifer Swainson

Get full text

Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers by Dmitriy Matveychuk, Rejish K. Thomas, Jennifer Swainson, Atul Khullar, Mary-Anne MacKay, Glen B. Baker, Serdar M. Dursun

Get full text